84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00851929 (ClinicalTrials.gov) | November 2008 | 24/2/2009 | Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension | Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension | Sarcoidosis;Pulmonary Hypertension | Drug: Ambrisentan | Medical University of South Carolina | Gilead Sciences | Completed | 18 Years | 99 Years | All | 16 | Phase 2/Phase 3 | United States |